Publications
- HER2 low nádory prsu a přístup k nim2023 | First Faculty of Medicine
- Eskalace a deeskalace léčby pacientek s karcinomem prsu v roce 20212022 | First Faculty of Medicine
- Review of tumor infiltrating lymphocytes assessment in breast cancer in routine diagnostic practice2021 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Characterization of circulating tumor cells in early breast cancer patients receiving neoadjuvant chemotherapy2021 | First Faculty of Medicine, Central Library of Charles University
- Predictive markers in breast cancer2021 | First Faculty of Medicine
- Treatment of HER2-positive breast cancer in 20202020 | First Faculty of Medicine
- Use of Trastuzumab for Neoadjuvant Therapy of HER2+ Breast Cancer - 5-Years of Experience in a Single Clinic2018 | First Faculty of Medicine
- Molecular characterization and heterogeneity of circulating tumor cells in breast cancer2017 | First Faculty of Medicine, Central Library of Charles University
- Breast cancer in young women2017 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Pokročilý triple negativní karcinom prsu2017 | First Faculty of Medicine
Loading network view...